Candriam SCA’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $309M | Sell |
713,392
-153,124
| -18% | -$46.5M | 1.39% | 11 |
|
|
2026
Q1 | $185M | Sell |
866,516
-175,995
| -17% | -$39.4M | 0.96% | 16 |
|
|
2025
Q4 | $178M | Sell |
1,042,511
-69,644
| -6% | -$10.8M | 0.89% | 16 |
|
|
2025
Q3 | $149M | Buy |
1,112,155
+81,888
| +8% | +$8.67M | 0.78% | 20 |
|
|
2025
Q2 | $100M | Buy |
1,030,267
+196,434
| +24% | +$15.6M | 0.58% | 31 |
|
|
2025
Q1 | $60.6M | Buy |
833,833
+148,202
| +22% | +$11.7M | 0.38% | 62 |
|
|
2024
Q4 | $49.5M | Buy |
+685,631
| New | +$52M | 0.29% | 79 |
|
|
2024
Q3 | – | Sell |
-1,145,150
| Closed | -$122M | – | 703 |
|
|
2024
Q2 | $122M | Sell |
1,145,150
-35,180
| -3% | -$3.37M | 0.74% | 26 |
|
|
2024
Q1 | $115M | Buy |
1,180,330
+351,220
| +42% | +$30.9M | 0.73% | 27 |
|
|
2023
Q4 | $64.9M | Buy |
829,110
+49,210
| +6% | +$3.35M | 0.45% | 50 |
|
|
2023
Q3 | $48.9M | Sell |
779,900
-569,200
| -42% | -$37.4M | 0.35% | 63 |
|
|
2023
Q2 | $86.7M | Buy |
1,349,100
+1,178,160
| +689% | +$66.4M | 0.63% | 30 |
|
|
2023
Q1 | $8.34M | Sell |
170,940
-2,750
| -2% | -$135K | 0.06% | 280 |
|
|
2022
Q4 | $7.3M | Sell |
173,690
-24,410
| -12% | -$1.02M | 0.05% | 325 |
|
|
2022
Q3 | $7.25M | Buy |
198,100
+103,280
| +109% | +$4.6M | 0.05% | 327 |
|
|
2022
Q2 | $4.04M | Buy |
94,820
+3,330
| +4% | +$159K | 0.03% | 357 |
|
|
2022
Q1 | $4.92M | Sell |
91,490
-73,380
| -45% | -$4.27M | 0.03% | 352 |
|
|
2021
Q4 | $11.9M | Sell |
164,870
-130,030
| -44% | -$8.15M | 0.08% | 240 |
|
|
2021
Q3 | $16.8M | Sell |
294,900
-163,940
| -36% | -$9.97M | 0.11% | 200 |
|
|
2021
Q2 | $31M | Buy |
458,840
+320,100
| +231% | +$20.2M | 0.21% | 110 |
|
|
2021
Q1 | $6.29M | Hold |
138,740
| – | – | 0.05% | 337 |
|
|
2020
Q4 | $6.55M | Sell |
138,740
-4,680
| -3% | -$197K | 0.05% | 346 |
|
|
2020
Q3 | $4.76M | Sell |
143,420
-168,610
| -54% | -$5.81M | 0.04% | 360 |
|
|
2020
Q2 | $10.1M | Buy |
312,030
+153,230
| +96% | +$4.18M | 0.11% | 215 |
|
|
2020
Q1 | $4.54M | Hold |
158,800
| – | – | 0.05% | 373 |
|
|
2019
Q4 | $4.64M | Buy |
158,800
+34,910
| +28% | +$927K | 0.05% | 380 |
|
|
2019
Q3 | $2.86M | Buy |
123,890
+16,660
| +16% | +$350K | 0.04% | 429 |
|
|
2019
Q2 | $2M | Buy |
107,230
+4,090
| +4% | +$77.6K | 0.03% | 515 |
|
|
2019
Q1 | $1.85M | Buy |
103,140
+6,680
| +7% | +$111K | 0.02% | 517 |
|
|
2018
Q4 | $1.31M | Sell |
96,460
-33,730
| -26% | -$483K | 0.02% | 536 |
|
|
2018
Q3 | $1.98M | Sell |
130,190
-85,930
| -40% | -$1.47M | 0.03% | 507 |
|
|
2018
Q2 | $3.74M | Buy |
216,120
+4,160
| +2% | +$80.1K | 0.06% | 351 |
|
|
2018
Q1 | $4.31M | Sell |
211,960
-510
| -0.2% | -$10.1K | 0.07% | 314 |
|
|
2017
Q4 | $3.91M | Buy |
212,470
+69,010
| +48% | +$1.36M | 0.07% | 319 |
|
|
2017
Q3 | $2.65M | Buy |
143,460
+39,150
| +38% | +$635K | 0.05% | 398 |
|
|
2017
Q2 | $1.48M | Sell |
104,310
-7,410
| -7% | -$109K | 0.03% | 516 |
|
|
2017
Q1 | $1.43M | Buy |
111,720
+28,970
| +35% | +$341K | 0.03% | 502 |
|
|
2016
Q4 | $875K | Buy |
82,750
+8,080
| +11% | +$82.1K | 0.02% | 536 |
|
|
2016
Q3 | $707K | Buy |
74,670
+19,230
| +35% | +$175K | 0.02% | 547 |
|
|
2016
Q2 | $466K | Buy |
55,440
+14,420
| +35% | +$116K | 0.01% | 563 |
|
|
2016
Q1 | $337K | Buy |
41,020
+7,870
| +24% | +$57.2K | 0.01% | 593 |
|
|
2015
Q4 | $263K | Buy |
33,150
+1,620
| +5% | +$12.2K | 0.01% | 524 |
|
|
2015
Q3 | $206K | Buy |
31,530
+5,540
| +21% | +$40.6K | 0.01% | 606 |
|
|
2015
Q2 | $211K | Sell |
25,990
-523,170
| -95% | -$4.11M | ﹤0.01% | 619 |
|
|
2015
Q1 | $3.86M | Buy |
+549,160
| New | +$4.34M | 0.08% | 297 |
|
Other funds holding LRCX
Candriam SCA's LRCX Position: Q2 2026 in Review
Candriam SCA reduced its Lam Research (LRCX) stake by 18% in Q2 2026, selling an estimated $46.5M and leaving 713,392 shares worth $309M. The position accounts for 1.39% of the portfolio, ranked #11.
Candriam SCA first reported a position in LRCX in Q1 2015 and has held it in 45 quarters since. 3,110 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Candriam SCA held 713,392 shares of Lam Research worth $309M as of Q2 2026.
- Candriam SCA sold 153,124 Lam Research shares in Q2 2026, an estimated $46.5M.
- Lam Research made up 1.39% of Candriam SCA's portfolio in Q2 2026, its #11 holding.
- Candriam SCA first reported a position in Lam Research in Q1 2015 and has held it in 45 quarters since.
- 3,110 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.